BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders The agreement will leverage strengths of two powerhouses dedicated to health to foster cross-border collaboration, building critical mass and consolidating sector to maintain Belgium’s position as a leader in Europe’s healthcare industry. Namur and Ghent, Belgium,…
Trasis: 20 years of innovation at the service of nuclear medicine 3.5 million patients treated worldwide by 2023 A new building in Liège, 350 employees and a promising future. Since it was founded in 2004 by Gauthier Philippart (CEO) and Jean-Luc Morelle (CTO), Trasis has set itself the ambitious goal…
One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments Brussels, March 26th, 2024 – One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches…
InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline. Researchers benefit from a comprehensive service offering, spanning early-stage discovery to phase I-IV trials, with meticulous planning and access to specialized services, aiming to set a new standard for excellence in the industry. Diepenbeek, Belgium and…
After the launch of call 38 by BioWin, the NucleoGlio project emerged as a consortium between the coordinating company Belgian Volition SRL, in collaboration with QUALIblood SA, and the institutes UNamur-NARILIS and UCLouvain-IREC. Belgian Volition SRL, QUALIblood, UNamur and UCLouvain, working together as a consortium, have been granted EUR 2.2…
PDC*line Pharma and partners receive €8.1M from Walloon region and Wallonia health cluster BioWin for personalized therapeutic vaccine project PDC*neo+ project aims to develop personalized therapeutic vaccine based on neoantigens for colorectal cancer Collaborative effort between biotechnology companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities UCLouvain–IREC/MIRO and ULB-BCTL…